Wang Jingjing, Chen Changxing, Zhao Zhanqi, Deng Puyu, Zhang Chenchen, Zhang Yu, Lv Hui, Chen Daonan, Xie Hui, Wang Ruilan
Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Institute of Technical Medicine, Furtwangen University, Villingen-Schwenningen, Germany.
J Intensive Med. 2024 Oct 18;5(1):43-50. doi: 10.1016/j.jointm.2024.07.007. eCollection 2025 Jan.
Awake prone positioning (APP) can reportedly reduce the need for intubation and help improve prognosis of patients with acute hypoxemic respiratory failure (AHRF) infected with COVID-19. However, its physiological mechanism remains unclear. In this study, we evaluated the effect of APP on lung ventilation in patients with moderate-to-severe AHRF to better understand the effects on ventilation distribution and to prevent intubation in non-intubated patients.
The prospective study was performed in the Department of Critical Care Medicine at Shanghai General Hospital, China, from January 2021 to November 2022. The study included patients with AHRF (partial pressure of oxygen [PaO]/inspired oxygen concentration [FiO] <200 mmHg or oxygen saturation [SpO]/FiO <235) treated with high-flow nasal oxygen. Electrical impedance tomography (EIT) measurements including center of ventilation (COV), global inhomogeneity (GI) index, and regional ventilation delay (RVD) index were performed in the supine position (T), 30 min after the start of APP (T), and 30 min returning to supine position after the APP (T). Clinical parameters like SpO, respiratory rate (RR), FiO, heart rate (HR), and ROX (the ratio of SpO as measured by pulse oximetry/FiO to RR) were also recorded simultaneously at T, T, and T. To evaluate the effect of the time points on the variables, Mauchly's test was performed for sphericity and repeated measures analysis of variance was applied with Bonferroni's multiple comparisons.
Ten patients were enrolled. The PaO/FiO ratio was (111.4±33.4) mmHg at the time of recruitment. ROX showed a significant increase after initiation of APP {median (interquartile range [IQR]): T: 7.5 (6.0-10.1) T: 7.6 (6.4-9.3) T: 8.3 (7.2-11.0), =0.043}. RR (=0.409), HR (=0.417), and SpO/FiO (=0.262) did not change significantly during prone positioning (PP). The COV moved from the ventral area to the dorsal area (T: 48.8%±6.2% T: 54.8%±6.8% T: 50.3%±6.1%, =0.030) after APP. The GI decreased significantly after APP (T: median=42.7 %, [IQR: 38.3%-47.5%] T: median=38.2%, [IQR: 34.6%-50.7%] T: median=37.4%, [IQR: 34.2%-41.4%], =0.049). RVD (=0.794) did not change after APP.
APP can improve ventilation distribution and homogeneity of lung ventilation as assessed by EIT in non-intubated patients with AHRF. Chinese Clinical Trial Registry Identifier: ChiCTR2000035895.
据报道,清醒俯卧位通气(APP)可减少插管需求,并有助于改善新型冠状病毒肺炎(COVID-19)感染所致急性低氧性呼吸衰竭(AHRF)患者的预后。然而,其生理机制尚不清楚。在本研究中,我们评估了APP对中重度AHRF患者肺通气的影响,以更好地了解其对通气分布的影响,并防止未插管患者进行插管。
本前瞻性研究于2021年1月至2022年11月在中国上海交通大学医学院附属瑞金医院重症医学科进行。研究纳入接受高流量鼻导管吸氧治疗的AHRF患者(氧分压[PaO₂]/吸入氧浓度[FiO₂]<200 mmHg或氧饱和度[SpO₂]/FiO₂<235)。在仰卧位(T₁)、APP开始后30分钟(T₂)和APP后恢复仰卧位30分钟(T₃)进行电阻抗断层扫描(EIT)测量,包括通气中心(COV)、整体不均匀性(GI)指数和区域通气延迟(RVD)指数。同时在T₁、T₂和T₃记录临床参数,如SpO₂、呼吸频率(RR)、FiO₂、心率(HR)和ROX(脉搏血氧饱和度测定的SpO₂/FiO₂与RR的比值)。为评估时间点对变量的影响,进行Mauchly球形检验,并采用Bonferroni多重比较的重复测量方差分析。
共纳入10例患者。入组时PaO₂/FiO₂比值为(111.4±33.4)mmHg。开始APP后ROX显著升高{中位数(四分位间距[IQR]):T₁:7.5(6.0 - 10.1);T₂:7.6(6.4 - 9.3);T₃:8.3(7.2 - 11.0),P = 0.043}。俯卧位(PP)期间RR(P = 0.409)、HR(P = 0.417)和SpO₂/FiO₂(P = 0.262)无显著变化。APP后COV从腹侧区域移至背侧区域(T₁:48.8%±6.2%;T₂:54.8%±6.8%;T₃:50.3%±6.1%,P = 0.030)。APP后GI显著降低(T₁:中位数 = 42.7%,[IQR:38.3% - 47.5%];T₂:中位数 = 38.2%,[IQR:34.6% - 50.7%];T₃:中位数 = 37.4%,[IQR:34.2% - 41.4%],P = 0.049)。APP后RVD(P = 0.794)无变化。
对于未插管的AHRF患者,EIT评估显示APP可改善肺通气的分布和均匀性。中国临床试验注册标识符:ChiCTR2000035895。